# ELAB (Pmgc Holdings Inc.) - SEC EDGAR Financial Statements

> Pmgc Holdings Inc. reported $590K in revenue and a net loss of $13.30M for the fiscal year ended December 31, 2025, with a 31.4% gross margin and a -1166.3% operating margin.

- Canonical: https://convexityos.com/fundamentals/ELAB
- Markdown: https://convexityos.com/fundamentals/ELAB.md
- SEC CIK: 0001840563
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:13 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001840563&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $590K | Dec 31, 2025 |
| Operating Income | FY 2025 | -$6.88M | -1166.3% margin |
| Net Income | FY 2025 | -$13.30M | -2253.5% net margin |
| Diluted EPS | FY 2025 | -- | Split-adjusted |
| Free Cash Flow | FY 2025 | -$6.38M | -1080.5% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $13.53M | Total debt: $5.25M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| **Revenue** | $590K | -- | $1.71M | $766K |
| Cost of Revenue | $405K | -- | $1.71M | $319K |
| **Gross Profit** | $185K | -- | $1.13M | $447K |
| Research & Development | $147K | $105K | $7.4K | $229K |
| Selling, General & Admin | -- | -- | $1.01M | $1.21M |
| Total Operating Expenses | $7.07M | $3.66M | $1.14M | $2.24M |
| **Operating Income** | -$6.88M | -- | -$6.4K | -$1.79M |
| **EBITDA** | -$6.79M | -- | $5.3K | -$1.78M |
| Interest Income | $118K | $13K | $5.6K | $7.7K |
| Interest Expense | $258K | $735K | $20K | $2.6K |
| Income Before Tax | -$7.75M | -$4.02M | -- | -- |
| Income Tax Expense | $31K | -- | -- | -- |
| **Net Income** | -$7.75M | -$6.25M | -$4.30M | -$1.80M |
| Basic EPS | -- | -- | -$0.40 | -$0.19 |
| **Diluted EPS** | -- | -- | -$0.40 | -$0.19 |
| Basic Shares Outstanding | 20.4K | 947 | 7.7K | 9.5M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $2.53M | $1.31M | $682K | -- | $286K | -- | -- | -- |
| Cost of Revenue | $1.93M | $921K | $452K | -- | $208K | -- | -- | -- |
| **Gross Profit** | $601K | $386K | $230K | -- | $78K | -- | -- | -- |
| Research & Development | $130K | $310K | $47K | $33K | $15K | $67K | $5.8K | $45K |
| Total Operating Expenses | $3.08M | $4.21M | $3.56M | $2.58M | $2.28M | $1.01M | $1.20M | $1.68M |
| **Operating Income** | -$2.48M | -$3.83M | -$3.33M | -- | -$2.20M | -- | -- | -- |
| **EBITDA** | -$2.19M | -$3.55M | -$3.17M | -- | -$2.16M | -- | -- | -- |
| Interest Income | $489K | $83K | $63K | $28K | $24K | $37K | $29K | $13K |
| Interest Expense | $488K | $582K | $474K | $230K | $17K | $2 | $10K | $51K |
| **Net Income** | -$2.41M | -$2.94M | -$4.97M | -$2.98M | -$2.59M | -$562K | -$1.61M | -$1.93M |
| Basic Shares Outstanding | 799.1K | 4.9M | 444.5K | -- | 2.2K | 14.8K | 6.5K | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $5.40M | $3.98M | $3.33M | $1.15M |
| Short-Term Investments | $572K | -- | -- | -- |
| **Cash & Short-Term Investments** | $5.97M | $3.98M | $3.33M | $1.15M |
| Accounts Receivable, Net | $245K | $5.3K | $3.1K | $13K |
| Inventory | $95K | -- | $496K | $230K |
| Other Current Assets | $95K | $5.3K | -- | -- |
| **Total Current Assets** | $6.87M | $6.05M | $4.92M | $1.55M |
| Property, Plant & Equipment, Net | $886K | $1.1K | $1.7K | $53K |
| Goodwill | $978K | -- | -- | -- |
| Intangible Assets | $2.89M | $2.80M | -- | -- |
| Long-Term Investments | -- | $139K | -- | -- |
| **Total Non-Current Assets** | $6.00M | $2.94M | $270K | $341K |
| **Total Assets** | $12.87M | $8.99M | $5.19M | $1.89M |
| Accounts Payable | -- | -- | $596K | $211K |
| Other Current Liabilities | -- | -- | $77K | $154K |
| **Total Current Liabilities** | $3.94M | $1.80M | $1.30M | $588K |
| **Total Non-Current Liabilities** | $1.09M | $534K | $65K | $173K |
| **Total Liabilities** | $5.03M | $2.33M | $1.36M | $761K |
| **Total Debt (incl. Leases)** | $1.22M | -- | $210K | $172.6M |
| Common Stock | $1 | $1 | $1 | $957 |
| Retained Earnings | -$21.02M | -$13.27M | -$7.02M | -$2.72M |
| Accumulated Other Comp. Income | -$2.3K | -$337 | $202 | $111 |
| **Total Stockholders' Equity** | $7.84M | $6.66M | $3.83M | $1.13M |
| Total Equity | $7.84M | $6.66M | $3.83M | $1.13M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $12.98M | $18.14M | $14.35M | $5.40M | $7.70M | -- | -- | $3.98M |
| Short-Term Investments | $548K | $651K | $733K | $572K | $804K | $625K | $557K | -- |
| **Cash & Short-Term Investments** | $13.53M | $18.79M | $15.09M | $5.97M | $8.50M | -- | -- | $3.98M |
| Accounts Receivable, Net | $1.23M | $422K | $428K | $245K | $271K | -- | -- | $5.3K |
| Inventory | $930K | $933K | $254K | $95K | $128K | -- | -- | -- |
| Other Current Assets | $134K | $182K | $115K | $95K | $98K | -- | -- | $5.3K |
| **Total Current Assets** | $16.56M | $20.83M | $16.39M | $6.87M | $9.77M | $7.30M | $6.82M | $6.05M |
| Property, Plant & Equipment, Net | $2.20M | $1.90M | $1.75M | $886K | $413K | -- | -- | $1.1K |
| Goodwill | $3.04M | $3.04M | $1.86M | $978K | $960K | -- | -- | -- |
| Intangible Assets | $5.73M | $5.99M | $3.80M | $2.89M | $2.55M | $2.07M | $2.07M | $2.80M |
| Long-Term Investments | $500K | -- | -- | -- | -- | -- | -- | $139K |
| **Total Non-Current Assets** | $116.5M | $15.73M | $9.65M | $6.00M | $5.17M | $2.07M | $2.07M | $2.94M |
| **Total Assets** | $133.1M | $36.56M | $26.03M | $12.87M | $14.94M | $9.38M | $8.89M | $8.99M |
| **Total Current Liabilities** | $13.03M | $15.33M | $11.30M | $3.94M | $5.46M | $326K | $760K | $1.80M |
| **Total Non-Current Liabilities** | $8.01M | $4.50M | $2.13M | $1.09M | $986K | $0 | $0 | $534K |
| **Total Liabilities** | $21.03M | $19.83M | $13.43M | $5.03M | $6.45M | $326K | $760K | $2.33M |
| **Total Debt (incl. Leases)** | $5.25M | $5.16M | $2.57M | $1.22M | $1.21M | -- | -- | -- |
| Common Stock | $89 | $615 | $194 | $1 | $74 | $148 | $71 | $1 |
| Retained Earnings | -$31.33M | -$28.93M | -$25.98M | -$21.02M | -$18.03M | -$15.44M | -$14.88M | -$13.27M |
| Accumulated Other Comp. Income | -- | -- | -- | -$2.3K | -$753 | -$1.2K | -$816 | -$337 |
| **Total Stockholders' Equity** | $12.11M | $16.74M | $12.61M | $7.84M | $8.49M | $9.05M | $8.13M | $6.66M |
| Total Equity | $11.64M | $16.74M | $12.61M | $7.84M | $8.49M | $9.05M | $8.13M | $6.66M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Net Income | -$7.75M | -$6.25M | -$4.30M | -$1.80M |
| Depreciation & Amortization | $96K | $546 | $12K | $6.5K |
| Stock-Based Compensation | -$19K | $97K | $488K | $172K |
| Change in Receivables | -$101K | -$13K | -$23K | -$12K |
| Change in Inventory | $148K | -$403K | -$266K | -$69K |
| Change in Payables | -- | -- | $467K | $65K |
| **Operating Cash Flow** | -$5.93M | -$5.49M | -$4.56M | -$1.59M |
| Capital Expenditure | -$442K | -$9.2K | -$11K | -$36K |
| **Free Cash Flow** | -$6.38M | -$5.50M | -$4.57M | -$1.62M |
| Acquisitions, Net | -$2.16M | -- | -- | -- |
| Purchases of Investments | -$1.79M | -$139K | -- | -- |
| **Investing Cash Flow** | -$2.77M | -$611K | -$11K | -$32K |
| Common Stock Issued | -- | $6.99M | $1.46M | -- |
| **Financing Cash Flow** | $10.12M | $6.76M | $6.74M | $2.36M |
| **Net Change in Cash** | $1.42M | $658K | $2.17M | $743K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.24M | -$2.94M | -$4.97M | -$2.98M | -$2.59M | -$562K | -$1.61M | -$1.93M |
| Depreciation & Amortization | $285K | $281K | $159K | $60K | $35K | $20 | $1.1K | $134 |
| Stock-Based Compensation | $355K | $175K | $8.2K | $11K | $13K | $16K | -$59K | $40K |
| Change in Receivables | -$795K | $410K | $120K | -$19K | $23K | -$28K | -$77K | -$21K |
| Change in Inventory | $2.3K | -$164K | -$115K | $23K | $102K | $0 | $23K | $87K |
| **Operating Cash Flow** | -$2.26M | -$1.99M | -$2.98M | -$1.75M | -$1.49M | -$1.35M | -$1.35M | -$2.00M |
| Capital Expenditure | -$361K | $28K | -$363K | -- | -- | -- | -- | $0 |
| **Free Cash Flow** | -$2.62M | -$1.96M | -$3.34M | -- | -- | -- | -- | -$2.00M |
| Acquisitions, Net | -$2.3K | -$3.83M | -$2.02M | -- | -- | -- | -- | -- |
| Purchases of Investments | -$504K | -$1.44M | -$1.44M | -$225K | -$569K | -$565K | -$430K | -- |
| **Investing Cash Flow** | -$757K | -$3.68M | -$2.48M | -$549K | -$2.20M | $197K | -$215K | -$439K |
| Common Stock Issued | -- | -- | -- | -- | -$239K | $0 | $1.48M | -- |
| **Financing Cash Flow** | $98.28M | $9.46M | $14.41M | -$1 | $5.71M | $1.47M | $2.94M | -- |
| **Net Change in Cash** | $95.26M | $3.79M | $8.95M | -$2.30M | $2.02M | $318K | $1.38M | -$2.44M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| **Gross Margin** | 31.4% | -- | 66.2% | 58.4% |
| **Operating Margin** | -1166.3% | -- | -0.4% | -233.7% |
| **Net Profit Margin** | -1313.0% | -- | -251.2% | -234.9% |
| Return on Equity (ROE) | -98.9% | -93.8% | -112.4% | -159.1% |
| Return on Assets (ROA) | -60.2% | -69.4% | -82.9% | -95.1% |
| Current Ratio | 1.74x | 3.36x | 3.79x | 2.64x |
| Quick Ratio | 1.72x | 2.22x | 3.41x | 2.25x |
| Debt to Equity | 0.16x | -- | 0.05x | 152.57x |
| **Revenue Growth (YoY)** | -- | -- | +123.5% | -- |
| Gross Profit Growth (YoY) | -- | -- | +153.6% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -109.8% | -80.6% | -88.1% | -98.9% | -78.9% | -62.0% | -79.4% | -93.8% |
| Return on Assets (ROA) | -10.0% | -36.9% | -42.7% | -60.2% | -44.9% | -59.8% | -72.6% | -69.4% |
| Current Ratio | 1.27x | 1.36x | 1.45x | 1.74x | 1.79x | 22.38x | 8.97x | 3.36x |
| Quick Ratio | 1.20x | 1.30x | 1.43x | 1.72x | 1.77x | -- | -- | 2.22x |
| Debt to Equity | 0.43x | 0.31x | 0.20x | 0.16x | 0.14x | -- | -- | -- |
| **Revenue Growth (YoY)** | +784.9% | -- | -- | -- | -45.8% | -- | -- | -- |
| Gross Profit Growth (YoY) | +670.8% | -- | -- | -- | -80.2% | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
